RWA Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.9M Sell
252,544
-3,308
-1% -$734K 0.6% 26
2025
Q4
$58.5M Buy
255,852
+2,724
+1% +$621K 0.64% 25
2025
Q3
$58.6M Sell
253,128
-18,851
-7% -$3.84M 0.67% 23
2025
Q2
$50.5M Sell
271,979
-23,142
-8% -$4.3M 0.63% 23
2025
Q1
$61.8M Sell
295,121
-15,910
-5% -$3.09M 0.78% 21
2024
Q4
$55.3M Buy
311,031
+4,664
+2% +$858K 0.68% 21
2024
Q3
$60.5M Sell
306,367
-13,165
-4% -$2.46M 0.75% 17
2024
Q2
$54.8M Buy
319,532
+12,521
+4% +$2.07M 0.72% 18
2024
Q1
$55.9M Sell
307,011
-12,903
-4% -$2.22M 0.75% 18
2023
Q4
$49.6M Buy
319,914
+235,137
+277% +$34.3M 0.71% 20
2023
Q3
$12.6M Buy
84,777
+2,730
+3% +$401K 0.28% 36
2023
Q2
$11.1M Buy
82,047
+9,818
+14% +$1.44M 0.24% 39
2023
Q1
$11.5M Buy
72,229
+1,544
+2% +$236K 0.28% 32
2022
Q4
$11.1M Buy
70,685
+2,466
+4% +$378K 0.28% 34
2022
Q3
$9.16M Buy
68,219
+1,792
+3% +$257K 0.64% 31
2022
Q2
$10.2M Buy
66,427
+1,715
+3% +$262K 0.69% 26
2022
Q1
$10.5M Buy
64,712
+2,333
+4% +$339K 0.68% 32
2021
Q4
$8.45M Buy
62,379
+1,286
+2% +$152K 0.57% 49
2021
Q3
$6.59M Buy
61,093
+611
+1% +$69.8K 0.49% 59
2021
Q2
$6.81M Sell
60,482
-19,172
-24% -$2.16M 0.51% 57
2021
Q1
$8.62M Buy
79,654
+10,258
+15% +$1.1M 0.7% 41
2020
Q4
$7.44M Sell
69,396
-3,211
-4% -$309K 0.66% 37
2020
Q3
$6.36M Buy
72,607
+5,143
+8% +$484K 0.67% 38
2020
Q2
$6.62M Buy
67,464
+401
+0.6% +$35.3K 0.81% 30
2020
Q1
$5.11M Buy
67,063
+287
+0.4% +$24.4K 0.72% 37
2019
Q4
$5.91M Sell
66,776
-401
-0.6% -$33.3K 0.59% 46
2019
Q3
$5.09M Buy
67,177
+1,582
+2% +$108K 0.54% 47
2019
Q2
$4.77M Sell
65,595
-2,761
-4% -$217K 0.51% 46
2019
Q1
$5.51M Sell
68,356
-283
-0.4% -$23.2K 0.63% 40
2018
Q4
$6.33M Buy
68,639
+5,211
+8% +$458K 0.83% 29
2018
Q3
$6M Buy
63,428
+1,208
+2% +$115K 0.67% 32
2018
Q2
$5.76M Buy
62,220
+915
+1% +$89.4K 0.64% 36
2018
Q1
$5.8M Sell
61,305
-49,168
-45% -$5.4M 0.75% 28
2017
Q4
$10.7M Sell
110,473
-1,364
-1% -$129K 1.2% 15
2017
Q3
$9.94M Sell
111,837
-15,058
-12% -$1.15M 1.12% 15
2017
Q2
$9.2M Buy
126,895
+1,365
+1% +$91.8K 1.13% 22
2017
Q1
$8.18M Buy
+125,530
New +$7.89M 1.07% 18

Other funds holding ABBV